Basal ganglia iron content in Parkinson's disease measured with magnetic resonance

Movement Disorders

Volumn 11, Issue 3, 1996, Pages 243-249

  Ye, Frank Q ^a,b   Allen, Peter S ^a   Martin, W R Wayne ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GLENROSE REHABILITATION HOSPITAL   (Canada)

Author keywords

Iron; Magnetic resonance imaging; Parkinson's disease

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; BASAL GANGLION; CELL MEMBRANE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; GLOBUS PALLIDUS; HUMAN; MEASUREMENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SYMPTOMATOLOGY; TECHNIQUE; TISSUE LEVEL;

ADULT; AGED; BASAL GANGLIA; FEMALE; GLOBUS PALLIDUS; HUMANS; IMAGE ENHANCEMENT; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PUTAMEN; REFERENCE VALUES;

EID: 0030005267     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110305     Document Type: Article

References (33)

1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
2. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, eds. Third Symposium on Parkinson's disease. Edinburgh: Livingstone, 1969:152-157.
3. Duvoisin RC. The evaluation of extrapyramidal disease. In: de Ajuriagerra J, ed. Monoamines: noyaux gris centraux et syndrome de Parkinson. Paris: Masson, 1970:313-325.
4. Fahn S, Elton RL. Unified Parkinson's disease rating scale. In: Fahn S, et al., eds. Recent developments in Parkinson's disease, Florham Park: Macmillan, 1987;2:153-163.
5. Hallgren B, Sourander P. The effect of age on the nonhaem iron in the human brain. J Neurochem 1958;3:41-51.
6. Hill JM, Switzer RC. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 1984;11: 595-602.
7. Riederer P, Sofic E, Rausch WD, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515-520.
8. Earle KM. Studies on Parkinson's disease including x-ray fluroescent spectroscopy of formalin fixed brain tissue. J Neuropathol Exp Neurol 1968;27:1-14.
9. Dexter DT, Wells FR, Lees AJ, et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 1989;52 1830-1836.
10. Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 1988;744.199-205.
11. Uitti RJ, Rajput AH, Rozdilsky B, et al. Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains. Can J Neurol Sci 1989; 16:310-314.
12. Youdim MBH, Ben-Schachar D, Yehuda S, Riederer P. The role of iron in the basal ganglia. Adv Neurology 1990;53: 155-162.
13. Drayer B, Burger P, Darwin R, et al. Magnetic resonance imaging of brain iron. AJNR 1986;7:373-380.
14. Antonini A, Leenders KL, Meier D, Oertel WH, Boesiger P, Anliker M. T2 relaxation time in patients with Parkinson's disease. Neurology 1993;43:697-700.
15. Ryvlin P, Broussolle E, Piollet H, Viallet F, Khalfallah Y, Chazot G. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic parkinson's disease. Arch Neurol 1995;52:583-588.
16. Ye FQ, Martin WRW, Hodder J, Allens PS. Brain iron imaging exploiting heterogeneous-susceptibility-enhanced proton relaxation. In: Proceedings of the 2nd Meeting of Society of Magnetic Resonance. Berkeley, CA: Society of Magnetic Resonance, 1994:5.
17. 2*-weighted MRI at 3T. Magn Reson Med 1994;32:335-341.
18. Gorrell JM, Ordridge RJ, Brown GG, Deniau J-C, Buderer NM, Helpern JA. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995;45: 1138-1143.
19. Connor JR, Menzies SL, St. Martin SM, Mufson EJ. Cellular distribution of transferrill, ferritin, and iron in normal and aged human brains. J Neurosci Res 1990;27:595-611.
20. Dexter DT, Jenner P, Schapira AHV, et al. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol 1992;32:S94-S100.
21. Mash DC, Sanchez-Ramos J, Weiner WJ. Distribution and number of transferrin receptors in Parkinson's disease and the MPTP-treated mice. Ann Neurol 1990;28:230-231.
22. Youdim MBH, Ben-Schachar D, Riederer P. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol Scand 1989;80:47-54.
23. Dexter DT, Carayon A, Vidailhet M, et al. Decreased ferritin levels in brain in Parkinson's disease. J Neurochem 1990;55:16-20.
24. Good PF, Olanow CW, Perl DP. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 1992;593:343-346.
25. Jellinger K, Kienzl E, Rumpelmair G, et al. Iron-melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis. J Neurochem 1992;59:1168-1171.
26. Chen JC, Hardy PA, Kucharczyk W, et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR 1993;14:275-281.
27. Jellinger K. Overview of morphological changes in Parkinson's disease. In: Yahr MD, Bergmann KJ, eds. Advances in neurology, vol. 45: Parkinson's disease. New York. Raven Press, 1987:1-18.
28. Lindvall O, Bjorklund A. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res 1979;172:169-173.
29. Lang AE, Curran T, Provias J, Bergeron C. Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging. Can J Neurol Sci 1994;21:311-318.
30. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic PD. J Neurol Neurosurg Psychiatry 1992;55:181-184.
31. Chen JC, Hardy PA, Clauberg M, et al. T2 values in the human brain: comparison with quantitative assays of iron and ferritin. Radiology 1989;173:521-526.
32. Ye FQ, Allen PS. Ferritin as a susceptibility agent. In: Proceedings of the 12th Annual Meeting of Society of Magnetic Resonance in Medicine. Berkeley, CA: Society of Magnetic Resonance, 1993:800.
33. Ye FQ, Martin WRW, Allen PS. Estimation of the iron concentration in excised grey matter by means of proton relaxation measurements. Magn Reson Med (1996 in press).